Clinical trial
Immunotherapy in Treating Patients With Resected Liver Metastases From Colon…
NCT00003433 · Duke Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003433 |
|---|---|
| Title | Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer |
| Official title | A Phase I/II Study of Active Immunotherapy With Carcinoembryonic Antigen RNA-Pulsed, Autologous, Cultured Dendritic Cells After Complete Resection of Hepatic Metastases of Colorectal Carcinoma |
| Lead sponsor | Duke Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | carcinoembryonic antigen RNA-pulsed DC cancer vaccine |
| Start date | Jun 1, 1998 |
| Completion | Aug 1, 2003 |
| First posted | Aug 13, 2003 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: